Comparison of the prognosis of primary and progressive muscle-invasive bladder cancer after radical cystectomy: A systematic review and meta-analysis
- 1 April 2018
- journal article
- review article
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 52, 214-220
Abstract
The aim of the study was to systematically review the relevant studies to evaluate the prognosis of primary and progressive muscle-invasive bladder cancer (MIBC) after radical cystectomy (RC) and provide a clue for the timing of RC in patients with progressive MIBC early at the time of high-risk non-muscle-invasive bladder cancer (NMIBC). PubMed, MEDLINE, EMBASE and the Cochrane Central Register of Controlled Trials were searched for eligible studies. We extracted hazard ratios (HRs) of overall survival (OS) and cancer-specific survival (CSS) and deaths at 5 and 10 years for each study and performed the meta-analysis using Review Manager 5.3. A total of 11 retrospective studies with 4102 patients were included in the meta-analysis. The pooled analysis suggested a similar CSS (HR: 1.18; 95% CI, 0.74, 1.87; p = 0.50) and OS (HR: 1.15; 95% CI, 0.82, 1.61; p = 0.43) between primary and progressive MIBC patients treated with RC. The results further indicated no significant differences between the two populations in terms of 5-year CSS rate (OR: 1.32; 95% CI, 0.90, 1.95; p = 0.16), 10-year CSS rate (OR: 0.83; 95% CI, 0.37, 1.83; p = 0.64) as well as 5-year OS rate (OR: 1.02; 95% CI, 0.66, 1.56; p = 0.94). Subgroup analysis according to the starting point of follow-up showed similar outcomes. The meta-analysis demonstrates comparable CSS and OS in patients with primary and progressive MIBC following RC. Novel risk stratifications and prospective trials are urgently needed to investigate the prognosis after RC of these two groups of patients, which could finally aid clinician decision making and select patients who would actually benefit from early RC.Keywords
Funding Information
- National Natural Science Foundation of China (81402110, 81672547, 81272820)
- Science and Technology Support Program of Sichuan Province (2015SZ0230-3)
- 1.3.5 Project for Disciplines of Excellence, West China Hospital, Sichuan University
This publication has 25 references indexed in Scilit:
- The natural history of secondary muscle-invasive bladder cancerBMC Urology, 2013
- Survival after cystectomy for invasive bladder cancerEuropean Journal of Surgical Oncology, 2010
- Distinctive Expression Pattern of ErbB Family Receptors Signifies an Aggressive Variant of Bladder CancerJournal of Urology, 2008
- Primary Invasive versus Progressive Invasive Transitional Cell Bladder Cancer: Multicentric Study of Overall Survival RateUrologia Internationalis, 2007
- The Difference in the Prognosis and Characteristics between the Progressive and Primary Muscle-invasive Bladder Cancer Treated with Radical CystectomyKorean Journal of Urology, 2007
- Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC TrialsEuropean Urology, 2006
- Cystectomy in Patients with High Risk Superficial Bladder Tumors Who Fail Intravesical BCG Therapy:European Urology, 2005
- Prognosis of Muscle-Invasive Bladder Cancer: Difference between Primary and Progressive Tumours and Implications for TherapyEuropean Urology, 2004
- Survival Rates after Radical Cystectomy according to Tumor Stage of Bladder Carcinoma at First PresentationUrologia Internationalis, 2004
- Cytokeratin expression patterns in low‐grade papillary urothelial neoplasms of the urinary bladderCancer, 2003